TRACEY WAY: Open Payments
NPI 1629589973 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 11 payments from 9 companies in 2025. Trend: 2023 $148 · 2024 $244 · 2025 $380
Food & beverage: $280Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $145 |
| Tempus AI, Inc | 1 | $64 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
| Incyte Corporation | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $26 |
| EMD Serono, Inc. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Caris MPI, Inc. | 1 | $17 |
Products named: RYBREVANT, XT CDX, KEYTRUDA, VENCLEXTA, ZYNYZ, Zoladex, PYRUKYND, MI CANCER SEEK.
Industry payments across CO — which companies pay providers there.
